@article{065ca2b86a284e4ebb4308f05461b0e9,
title = "Divergent reprogramming routes lead to alternative stem-cell states",
abstract = "Pluripotency is defined by the ability of a cell to differentiate to the derivatives of all the three embryonic germ layers: ectoderm, mesoderm and endoderm. Pluripotent cells can be captured via the archetypal derivation of embryonic stem cells or via somatic cell reprogramming. Somatic cells are induced to acquire a pluripotent stem cell (iPSC) state through the forced expression of key transcription factors, and in the mouse these cells can fulfil the strictest of all developmental assays for pluripotent cells by generating completely iPSC-derived embryos and mice. However, it is not known whether there are additional classes of pluripotent cells, or what the spectrum of reprogrammed phenotypes encompasses. Here we explore alternative outcomes of somatic reprogramming by fully characterizing reprogrammed cells independent of preconceived definitions of iPSC states. We demonstrate that by maintaining elevated reprogramming factor expression levels, mouse embryonic fibroblasts go through unique epigenetic modifications to arrive at a stable, Nanog-positive, alternative pluripotent state. In doing so, we prove that the pluripotent spectrum can encompass multiple, unique cell states.",
author = "Tonge, {Peter D.} and Corso, {Andrew J.} and Claudio Monetti and Hussein, {Samer M.I.} and Puri, {Mira C.} and Michael, {Iacovos P.} and Mira Li and Lee, {Dong Sung} and Mar, {Jessica C.} and Nicole Cloonan and Wood, {David L.} and Gauthier, {Maely E.} and Othmar Korn and Clancy, {Jennifer L.} and Thomas Preiss and Grimmond, {Sean M.} and Shin, {Jong Yeon} and Seo, {Jeong Sun} and Wells, {Christine A.} and Rogers, {Ian M.} and Andras Nagy",
note = "Funding Information: Acknowledgements We are grateful for A. Bang{\textquoteright}s expertise and assistance regarding flow cytometry. We thank M. Gertsenstein and M. Pereira for chimaera production, and K. Harpal for teratoma sectioning. We would also like to acknowledge the assistance and support of lab colleagues, collaborators and all the members of the Project Grandiose Consortium who are too numerous to name individually but who made a positive impact onthis research. A.N. is Tier 1 Canada ResearchChairin Stem Cells and Regeneration. This work was supported by grants awarded to A.N. and I.M.R. from the Ontario ResearchFundGlobalLeadership Round inGenomics andLifeSciencesgrants (GL2), to A.N. from the Canadian stem cell network (9/5254 (TR3)) and Canadian Institutes of Health Research (CIHR MOP102575), to J.-S.S. by the South Korean Ministry of Knowledge Economy (no. 10037410), SNUCM research fund (grant no. 0411-20100074), and Macrogen Inc. (no. MGR03-11 and 12), to S.G. from the Australian Research Council (no. SR110001002), and to C.A.W. by a Queensland government Smart Futures Fellowship and an ARC by Stem Cells Australia and to T.P. grants from NHMRC and ARC. Publisher Copyright: {\textcopyright} 2015 Macmillan Publishers Limited. All rights reserved.",
year = "2014",
month = dec,
day = "11",
doi = "10.1038/nature14047",
language = "English (US)",
volume = "516",
pages = "192--197",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7530",
}